Sort
261,768 grants matching “gene therapy”
Drug development for tuberous sclerosis complex and other pediatric epileptogenic diseases using neurovascular and cardiac microphysiological models
$1,142,940John Peter Wikswo · Vanderbilt University · UH3 · FY2020 · TR
Structure and function of eukaryotic DNA transposases
$1,142,894Frederick Dyda · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2017 · DK
Defining and Manipulating Epigenomic Regulators in Endogenous Systems
$1,142,798Jordan Leslie Meier · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Investigating mechanisms of bladder tumorigenesis
$1,142,525Abdul Banday · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Identification of Susceptibility Genes for Essential Tremor
$1,142,481Lorraine N Clark · Columbia University Health Sciences · R01 · FY2017 · NS
Inborn Errors of Cholesterol Synthesis
$1,142,331Forbes Porter · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2014 · HD
Center for Gene Therapy of Cystic Fibrosis
$1,142,254John F Engelhardt · University Of Iowa · P30 · FY2019 · DK
Myelodysplasia
$1,142,177Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL
A Clinical Trial of AAV2-BDNF Gene Therapy in Alzheimer's Disease
$1,141,927Mark H Tuszynski · University Of California, San Diego · R01 · FY2022 · AG
Targeting apoptotic cells to enhance radiotherapy
$1,141,784Jianghong Rao · Stanford University · R01 · FY2025 · CA
Survey and SEER Data Collection Core
$1,141,690Nancy K Janz · University Of Michigan At Ann Arbor · P01 · FY2012 · CA
Understanding the dynamic interactions between tau pathology and microgliamediated inflammation in Alzheimer's Disease
$1,141,642Ajay Gupta · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · AG
Dissecting Oligogenic Biomarkers in Ashkenazi Jews with Parkinson Disease
$1,141,563Rachel Saunders-Pullman · Icahn School Of Medicine At Mount Sinai · U01 · FY2019 · NS
TREATMENT OF ADDICTIONS-BIOLOGICAL CORRELATES
$1,141,431Mary J Kreek · Rockefeller University · P60 · FY2012 · DA
Center for Narcolepsy and Related Disorders (P50)
$1,141,430Emmanuel J Mignot · Stanford University · P50 · FY2015 · NS
Novel Mechanistic Targets of Steroid Hormones in the Brain
$1,141,384Meharvan Singh · University Of North Texas Hlth Sci Ctr · P01 · FY2017 · AG
Novel Biologic Therapies for GVHD
$1,141,368Leslie S Kean · Boston Children'S Hospital · R01 · FY2025 · HL
DEVELOPMENT OF A NOVEL DRUG CANDIDATE WITH A FIRST-in-CLASS MECHANISM FOR SMOKING CESSATION, RELAPSE and ABSTINENCE
$1,141,152Nurulain T Zaveri · Astraea Therapeutics, Llc · U01 · FY2018 · DA
Texas NeuroAIDS Research Center
$1,141,123Benjamin B. Gelman · University Of Texas Med Br Galveston · U24 · FY2016 · MH
Texas NeuroAIDS Research Center
$1,141,123Benjamin B. Gelman · University Of Texas Med Br Galveston · U24 · FY2015 · MH
Texas NeuroAIDS Research Center
$1,141,123Benjamin B. Gelman · University Of Texas Med Br Galveston · U24 · FY2017 · MH
Molecular and Cellular Mechanisms of Vascular Anomalies
$1,141,039Harvard University (Medical School) · P01 · FY2003 · AR
Microphysiological systems for modeling autoimmunity in type 1 diabetes
$1,141,032Ben Z Stanger · University Of Pennsylvania · UG3 · FY2019 · DK
Center for Gene Therapy of Cystic Fibrosis
$1,140,938John F Engelhardt · University Of Iowa · P30 · FY2016 · DK
Novel Small-Molecule Therapies for CF
$1,140,903Alan S Verkman · University Of California, San Francisco · P30 · FY2011 · DK